92 related articles for article (PubMed ID: 3469468)
41. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
42. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
43. Influence of sex steroids on development of cultured fetal rat metatarsal bones.
Chamoux E; Coxam V; Lebecque P; Davicco MJ; Miller SC; Barlet JP
Growth Dev Aging; 1997; 61(2):79-91. PubMed ID: 9348474
[TBL] [Abstract][Full Text] [Related]
44. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
van Dierendonck JH; Cornelisse CJ; van der Linden PW; van Putten LM; van de Velde CJ
Cancer Res; 1987 Aug; 47(15):4093-8. PubMed ID: 3607751
[TBL] [Abstract][Full Text] [Related]
45. In vivo influence of androgens on the cell kinetics and chromatin pattern of the MXT mouse mammary tumor treated or not by aminoglutethimide.
de Launoit Y; Kiss R
J Cancer Res Clin Oncol; 1989; 115(2):129-38. PubMed ID: 2469677
[TBL] [Abstract][Full Text] [Related]
46. Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.
Kubota T; Josui K; Fukutomi T; Kitajima M
Anticancer Res; 1995; 15(4):1275-8. PubMed ID: 7654008
[TBL] [Abstract][Full Text] [Related]
47. Kinetic and morphometric responses of heterogeneous populations of experimental breast cancer cells in vivo.
Lancaster S; English HF; Demers LM; Manni A
Cancer Res; 1988 Jun; 48(11):3276-81. PubMed ID: 3365706
[TBL] [Abstract][Full Text] [Related]
48. Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia.
Zeller WJ; Schreiber J; Petru E; Eisenbrand G
Arzneimittelforschung; 1989 Dec; 39(12):1577-9. PubMed ID: 2624608
[TBL] [Abstract][Full Text] [Related]
49. Characterization and estrogen stimulation of cytoplasmic progesterone receptor in the ovarian-dependent MXT-3590 mammary tumor line.
Watson CS; Medina D; Clark JH
Cancer Res; 1979 Oct; 39(10):4098-104. PubMed ID: 476646
[No Abstract] [Full Text] [Related]
50. Phenotypic change of the transplantable MXT mammary adenocarcinoma into mixed bone producing sarcoma-like tumors.
Kiss R; Devleeschouwer N; Paridaens RJ; Danguy A; Heuson JC; Atassi G
Anticancer Res; 1986; 6(4):753-9. PubMed ID: 3463244
[TBL] [Abstract][Full Text] [Related]
51. Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.
de Launoit Y; Kiss R
In Vitro Cell Dev Biol; 1989 Jul; 25(7):585-91. PubMed ID: 2753847
[TBL] [Abstract][Full Text] [Related]
52. [Studies on the anti-tumor effect of the E2 carrier drug and its mechanism].
Tanaka K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):823-30. PubMed ID: 3598276
[TBL] [Abstract][Full Text] [Related]
53. Influence of hormono- and/or chemotherapy on the MXT mouse mammary tumor as monitored by 31P MRS.
Scheiber C; Kiss R; De Launoit Y; Sijens P; Frühling J
Eur J Cancer; 1990 Mar; 26(3):241-51. PubMed ID: 2141481
[TBL] [Abstract][Full Text] [Related]
54. The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.
Michna H; Schneider MR; Nishino Y; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):447-53. PubMed ID: 2626038
[TBL] [Abstract][Full Text] [Related]
55. Histological staining by tritiated actinomycin D: a useful tool to study neoplastic cell heterogeneity and estrogen sensitivity of mammary tumors.
Kiss R; Leclercq G; Danguy A
Oncology; 1985; 42(2):129-32. PubMed ID: 2581200
[TBL] [Abstract][Full Text] [Related]
56. The later administration of progesterone more rapidly activates dormant mouse mammary tumor cells initiated by 3'-methyl-4-dimethylaminoazobenzene.
Yamamoto R; Tatsuta M; Yamamoto T; Terada N
Cancer Lett; 1996 Feb; 100(1-2):41-5. PubMed ID: 8620452
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines.
Kiss R; de Launoit Y; Wouters W; Deslypere JP; Lescrainier JP; Paridaens R; Vokaer A; Decoster R; Pasteels JL
Eur J Cancer Clin Oncol; 1989 May; 25(5):837-43. PubMed ID: 2737220
[TBL] [Abstract][Full Text] [Related]
58. In vivo mitogenic effects of estradiol on colon cancers: role of gastrin and gastrin receptors.
Singh P; Reubi JC; Rajakumar G; Guo YS; Prioux H; Chicone L
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):49-60. PubMed ID: 8338790
[TBL] [Abstract][Full Text] [Related]
59. Effects of estradiol and progesterone on seizure sensitivity in oophorectomized DBA/2J mice and C57/EL hybrid mice.
Hom AC; Leppik IE; Rask CA
Neurology; 1993 Jan; 43(1):198-204. PubMed ID: 8423885
[TBL] [Abstract][Full Text] [Related]
60. A transplantable pregnancy-dependent mammary tumor line (TPDMT-4) in strain DDD mice.
Matsuzawa A; Yamamoto T
Gan; 1974 Aug; 65(4):307-15. PubMed ID: 4426477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
